Portal Instruments appoints Bart Burgess as AVP Product Management and Strategy

Portal Instruments is pleased to welcome Mr. Bart Burgess as Associate Vice President Product Management and Strategy. Mr. Burgess will help define and execute Portal’s product strategy and  lead the development of  strategic business partnerships.

Read More

Portal to moderate panel at Drug Delivery Partnerships

Portal Instruments to moderate the panel "De-Risking Partnerships" on Thursday, September 24th, 10:50 am at DDP.

Read More

Our Vision is a Needle-Free World

Portal Instruments was founded with the goal to completely disrupt how injections are given and to replace the needle and syringe with a modern, convenient and safe technology.  Our Vision is a Needle-Free World.

Read More

Portal Instruments - man standing in warehouse

Portal Instruments: Team, Company, and Community during COVID-19

Portal continues to move forward despite Corona virus challenges.

Read More

Portal Instruments - cartridge

The Innovation in Needle-Free Primary Drug Containers

Learn more about Portal's innovative primary container from our partner, Gerresheimer.

Read More

Portal Instruments - Patrick Anquetil CEO and Co-Founder

The 3-D Chess of Business

Jay Sparks, host of Finding Unique Value podcast, chats with Patrick Anquetil, CEO and co-founder of Portal Instruments, about how he leveraged his unique science and business background to create value and solve an unmet need with potential to help millions of people.

Read More

LEO Logo

Portal announces 2nd major pharma partnership with LEO Pharma

LEO Pharma and Portal Instruments today announced a global collaboration and license agreement to develop Portal’s innovative needle-free drug delivery system for use in combination with LEO Pharma’s portfolio of investigational and approved medicines.

Read More

Ideas Graphic

De-Risking the Technical Partnership

At Portal, we have taken deliberate steps to identify and “de-risk” the process of partnering with us, from a technical perspective.

Read More